[DISCLOSURE] Boryung Pharmaceutical (003850) announced on July 28 that is has acquired 60,000 shares of Vizencell worth 1.5 billion won (US$1.3 million). The acquired shares account for 32.76% of the entire stock.

This amounts to 0.77% of the firm’s equity capital.